Astellas Steps Tentatively Into Global Vaccines, Following Path Of Japanese Competitors
This article was originally published in PharmAsia News
Astellas Pharma Inc. is making forays into the vaccines segment, with the support of development firm ClearPath Development Company to accelerate the process.
You may also be interested in...
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?